1. Home
  2. IMUX vs FJET Comparison

IMUX vs FJET Comparison

Compare IMUX & FJET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Immunic Inc.

IMUX

Immunic Inc.

HOLD

Current Price

$16.27

Market Cap

209.2M

Sector

Health Care

ML Signal

HOLD

Logo Starfighters Space Inc. Common Stock

FJET

Starfighters Space Inc. Common Stock

HOLD

Current Price

$4.23

Market Cap

216.9M

ML Signal

HOLD

Company Overview

Basic Information
Metric
IMUX
FJET
Founded
2016
2022
Country
United States
United States
Employees
66
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Air Freight/Delivery Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
209.2M
216.9M
IPO Year
2013
2026

Fundamental Metrics

Financial Performance
Metric
IMUX
FJET
Price
$16.27
$4.23
Analyst Decision
Strong Buy
Analyst Count
6
0
Target Price
$36.00
N/A
AVG Volume (30 Days)
140.8K
632.1K
Earning Date
05-14-2026
04-15-2026
Dividend Yield
N/A
N/A
EPS Growth
38.00
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.51
$3.39
52 Week High
$16.86
$28.56

Technical Indicators

Market Signals
Indicator
IMUX
FJET
Relative Strength Index (RSI) 66.47 51.36
Support Level $0.74 $3.39
Resistance Level N/A $4.95
Average True Range (ATR) 1.04 0.28
MACD 0.28 0.12
Stochastic Oscillator 90.27 94.12

Price Performance

Historical Comparison
IMUX
FJET

About IMUX Immunic Inc.

Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function. It operates in one segment which is Life science segment.

About FJET Starfighters Space Inc. Common Stock

Starfighters Space Inc is a commercial aerospace company based at NASA's Kennedy Space Center in Florida, with an additional base of operations at Midland International Air & Space Port in Texas, and has a fleet of seven F-104 Fighter jets that are capable of flying MACH 2+. Its activities include air launch operations, pilot and space flight training, support research, hypersonic testing, and other aerospace development programs. The company has one operating segment, which is principally the operations of F-104 Fighter jets and the development of infrastructure for orbital space launch.

Share on Social Networks: